McLean Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.63M Sell
1,420
-21
-1% -$21.5K 0.22% 43
2026
Q1
$1.33M Buy
1,441
+8
+0.6% +$8.11K 0.23% 44
2025
Q4
$1.54M Sell
1,433
-32
-2% -$30.6K 0.28% 41
2025
Q3
$1.24M Sell
1,465
-30
-2% -$22.3K 0.26% 45
2025
Q2
$1.16M Buy
1,495
+4
+0.3% +$3.11K 0.31% 43
2025
Q1
$1.08M Buy
1,491
+29
+2% +$24.1K 0.36% 40
2024
Q4
$1.13M Sell
1,462
-284
-16% -$235K 0.34% 40
2024
Q3
$1.55M Buy
1,746
+270
+18% +$243K 0.47% 33
2024
Q2
$1.39M Buy
1,476
+39
+3% +$31.2K 0.45% 35
2024
Q1
$1.09M Buy
1,437
+1
+0.1% +$712 0.37% 38
2023
Q4
$888K Sell
1,436
-3
-0.2% -$1.75K 0.33% 40
2023
Q3
$833K Hold
1,439
0.34% 40
2023
Q2
$675K Buy
1,439
+26
+2% +$10.9K 0.26% 50
2023
Q1
$485K Sell
1,413
-183
-11% -$61.7K 0.2% 59
2022
Q4
$584K Buy
1,596
+96
+6% +$34K 0.2% 57
2022
Q3
$490K Buy
1,500
+31
+2% +$9.82K 0.19% 59
2022
Q2
$485K Buy
1,469
+64
+5% +$19.2K 0.19% 57
2022
Q1
$402K Buy
1,405
+33
+2% +$8.49K 0.3% 62
2021
Q4
$351K Sell
1,372
-2
-0.1% -$507 0.14% 77
2021
Q3
$341K Buy
1,374
+149
+12% +$36.8K 0.13% 83
2021
Q2
$285K Buy
1,225
+95
+8% +$19.1K 0.13% 81
2021
Q1
$206K Buy
+1,130
New +$221K 0.16% 100

Other funds holding LLY

McLean Asset Management's LLY Position: Q2 2026 in Review

McLean Asset Management reduced its Eli Lilly (LLY) stake by 1.5% in Q2 2026, selling an estimated $21.5K and leaving 1,420 shares worth $1.63M. The position accounts for 0.22% of the portfolio, ranked #43.

McLean Asset Management first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. 4,631 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • McLean Asset Management held 1,420 shares of Eli Lilly worth $1.63M as of Q2 2026.
  • McLean Asset Management sold 21 Eli Lilly shares in Q2 2026, an estimated $21.5K.
  • Eli Lilly made up 0.22% of McLean Asset Management's portfolio in Q2 2026, its #43 holding.
  • McLean Asset Management first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on McLean Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.